期刊文献+

埃他卡林新衍生物激活ATP敏感性钾通道的亚型选择性 被引量:4

Selectivity of new iptakalim derivatives on the subtypes of ATP-sensitive potassium channels
下载PDF
导出
摘要 目的研究埃他卡林新衍生物对不同亚型KATP通道的选择性作用。方法在特异性表达Kir6.2/SUR1、Kir6.2/SUR2A、Kir6.1/SUR2B3种不同亚型KATP通道的HEK-293细胞模型上,分别给予0.1、1.0、10、100×10-6mol.L-1的埃他卡林新衍生物,研究其作用前后DiBAC4(3)细胞荧光强度的变化,评价其对克隆表达的不同亚型KATP通道的选择性作用。结果7个埃他卡林新衍生物可激活KATP通道,其中衍生物(3)、(7)、(8)、(9)、(12)和(14)对3个亚型的KATP通道均具有激活作用,衍生物(7)对Kir6.2/SUR2A亚型的激活作用最强;衍生物(6)纳他卡林(natakalim)仅激活Kir6.1/SUR2B亚型,对Kir6.2/SUR2A和Kir6.2/SUR1亚型均无激活作用。结论纳他卡林为Kir6.1/SUR2B亚型高选择性开放剂。 Aim To investigate the seletive actions of new iptakalim' s derivatives on different subtypes of ATP-sensitive potassium channels. Method In HEK- 293 cells expressing different recombinant KATP channels (Kir6.2/SUR1, Kir6.2/SUR2A and Kir6. 1/ SUR2B), the selectivty of those novel derivatives on KATP channels were examined using fluorescence-based assays. Result In HEK-293 cells heterologously expressing Kit6. 2/SUR1, Kit6. 2/SUR2A and Kir6. 1/ SUR2B recombinant KATP channels, these compounds (3), (7), (8), (9), (12) and (14) at concentrationsof 0. 1, 1.0, 10, and 100 × 10-6 mol · L^-1. caused decreases in fluorescence responses using DiBAC4 (3), while the compound (6) natakalim caused decreases in fluorescence responses for Kit6. 1/SUR2B recombinant KATP channels not for Kir6.2/SUR1 and Kit6.2/SUR2A recombinant KATP channels. Conclusion Natakalim showed high selectivity on the Kit6. 1/SUR2B subtype of KATP channels.
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第11期1427-1430,共4页 Chinese Pharmacological Bulletin
基金 国家高技术研究发展计划(863计划)重大专项基金资助(No2002AA2Z3137) 军队杰出人才资助项目(No06J023)
关键词 KATP通道 HEK-293细胞 纳他卡林 埃他卡林衍生物 KATP channels HEK-293 cells iptakalim' sderivatives natakalim
  • 相关文献

参考文献15

  • 1Ashcroft S J H, Ashcroft F M. Properties and functions of ATP - sensitive K^+ channels[ J]. Cell Signal, 1990,2 : 197 - 214.
  • 2Wickenden AD. K^+ channels as therapeutic drug targets [ J]. Pharmacol Ther ,2002 ,94 : 157 - 82.
  • 3Lawson K. Potassium channel activation: a potential therapeutic approach[J]. Pharmacol Ther, 1996,70 : 39 - 64.
  • 4Wang H, Tang Y, Wang L, et al. ATP-sensitive potassium channel openers and 2,3-dimethyl - 2-butylamine derivatives [ J]. Curr Med Chem, 2007,14 (2) : 133 - 55.
  • 5Chen Y P, Qiu C R, Wang H. Cardiovascular pharmacological characterization of novel 2,3-dimethyl-2-butylamine derivatives in rats[ J]. Life Sci,2004,75:2131 - 42.
  • 6Epps D E, Wolfe M L, Groppi V. Characterization of the steadystate and dynamic fluorescence properties of the potential - sensitive dye his-( 1,3-dibutylbarbituric acid ) trimethine oxonol ( Dibae4( 3 ) in model systems and cells [ J ]. Chem Phys Lipids, 1995,69 : 137 - 50.
  • 7Dorn A, Hermann F, Ebneth A, et al. Evaluation of a highthroughput fluorescence assay method for hERG potassium channel inhibition [ J ]. J Biomol Screen, 2005,10:339 - 47.
  • 8陈玉萍,崔文玉,汪海.埃他卡林对K_(ATP)通道亚型选择性作用的研究[J].中国药理学通报,2006,22(3):278-284. 被引量:11
  • 9赵文晓,戚志平,白云龙,张莹,赵学玲,吕延杰,李宝馨,杨宝峰.白藜芦醇对HERG钾通道电生理功能的影响[J].中国药理学通报,2007,23(7):865-869. 被引量:6
  • 10Aguilar-Bryan L, Nichols C G, Wechsler S W, et al. Cloning of the βcell high-affinity sulfonylurea receptor: A regulator of insulin secretion [ J ]. Science, 1995,268:423 - 6.

二级参考文献27

  • 1杨宝峰,单宏丽,龚冬梅,董德利,杜智敏.抗心律失常药物作用最佳靶点研究[J].哈尔滨商业大学学报(自然科学版),2002,18(1):1-5. 被引量:31
  • 2张红雨,徐长庆,李宏霞,李鸿珠,韩丽萍,孙轶华,李宝馨,杨宝峰.白藜芦醇抗心律失常和抗心肌缺血作用研究[J].中国药理学通报,2006,22(3):383-384. 被引量:33
  • 3Coghlan M J,Carroll W A,Gopalakrishnan M.Recent developments in the biology and medicinal chemistry of potassium channel modulators:Update from a decade of progress[J].J Med Chem,2001,44:1627-53.
  • 4Agvilar-Bryan L,Clement LJP 4th,Gonzalez G.Toward understanding the assembly and structure of KATP channels[J].Physiol Rev,1998,78:227-45.
  • 5Lazdunsky M.ATP-sensitive potassium channels:An overview[J].J Cardiovasc Pharmacol,1994,24(suppl):S1-5.
  • 6Seino S,Miki T.Physiological and pathophysiological roles of ATP-sensitive K+ channels[J].Pro Biophysic Mol Biol,2003,81:133-76.
  • 7Yokoshiki H,Sunagawa M,Seki T,Sperelakis N.ATP-sensitive K+ channels in pancreatic,cardiac,and vascular smooth muscle cells[J].Am J Physiol,1998,274(Cell Physiol 43):C25-37.
  • 8Kazic T,Gojkovic-Bukarica L.Ion channels and drug development focus on potassium channels and their modulators[J].Med Biol,1999,6(1),23-30.
  • 9Wright J M.Choosing a first-line drug in the management of elevated blood pressure:What is the evidence? 3:Angiotensin-converting-enzyme inhibitors[J].CMAJ,2000,163:293-6.
  • 10Zerangue N,Schwappach B,Jan Y N,Jan L Y.A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channels[J].Neuron,1999,22:537-48.

共引文献15

同被引文献53

  • 1陈玉萍,崔文玉,汪海.埃他卡林对K_(ATP)通道亚型选择性作用的研究[J].中国药理学通报,2006,22(3):278-284. 被引量:11
  • 2Noma A. ATP-regulated K^+ channels in cardiac muscle [ J ]. Nature, 1983,305 (5930) : 147 - 8.
  • 3Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K^+ channels[ J]. Prog Biophys Mol Biol, 2003,81 : 133 -76.
  • 4Grover G J, Garlid K D. ATP-Sensitive Potassium Channels: A Review of their Cardioprotective Pharmacology[ J]. J Mol Cell Cardiol, 2000,32(4) :677 -95.
  • 5Rodrigo G C, Standen N B. ATP-sensitive potassium channels [ J ]. Curr Pharm Design, 2005,11 ( 15 ) : 1915 - 40.
  • 6Wickenden A D. K^+ channels as therapeutic drug targets [ J]. Pharmacol Ther, 2002,94 : 157 - 82.
  • 7Edwards G, Weston A H. Recent advances in the pharmacology and therapeutic potential of potassium channel openers [ J ]. Exp Opin Invest Drugs, 1996,5 : 1453 - 64.
  • 8Aguilar-Bryan L, Nichols C G, Wechsler S W, et al. Cloning of the βcell high-affinity sulfonylurea receptor: A regulator of insulin secretion [ J ]. Science, 1995,268:423 - 6.
  • 9Liss B, Bruns R, Roeper J. Alternative sulfonylurea receptor expression defines metabolic sensitivity of KATP channels in dopaminergic midbrain neurons[ J]. EMBO J, 1999,18:833 - 46.
  • 10Babenko A, Gonzalez G, Aguilar-Bryan L,et al. Reconstituted human cardiac KATP channels. Functional identity with the native channels from the sarcolemma of human ventricular cells [ J ]. Circ Res, 1998,83:1132-43.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部